Search research articles
Contact Us
Filters
Showing results (451-460 of 563) with videos related to
Page
of 57
Sort By:
International Journal of Antimicrobial Agents
|
July 2, 1999
Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates
L J Smeijsters, F F Franssen, L Naesens, et al.
Journal of Medicinal Chemistry
|
March 17, 1995
3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties
S M Siddiqi, X Chen, J Rao, et al.
The Journal of Infectious Diseases
|
February 10, 1999
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group
J P Kleim, M Winters, A Dunkler, et al.
AIDS (London, England)
|
July 24, 1998
Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent
J Balzarini, L Naesens, E Verbeken, et al.
Journal of Medicinal Chemistry
|
July 31, 1998
Discovery of type II (covalent) inactivation of S-adenosyl-L-homocysteine hydrolase involving its "hydrolytic activity": synthesis and evaluation of dihalohomovinyl nucleoside analogues derived from adenosine
S F Wnuk, Y Mao, C S Yuan, et al.
FEBS Letters
|
November 20, 1998
7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase
J Balzarini, A E Gamboa, R Esnouf, et al.
FEBS Letters
|
October 24, 2000
Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase
J Balzarini, B Degrève, A Esteban-Gamboa, et al.
Antiviral Research
|
January 1, 1994
Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates
R Caliò, N Villani, E Balestra, et al.
Antiviral Research
|
June 1, 1993
Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection
R A Heijtink, G A De Wilde, J Kruining, et al.
Molecular Pharmacology
|
December 1, 1992
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents
N Yamamoto, D Schols, E De Clercq, et al.
Page
of 57
Search research articles
Search
Showing results (451-460 of 563) with videos related to
Sort By:
Page
of 57
International Journal of Antimicrobial Agents
|
July 2, 1999
Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates
L J Smeijsters, F F Franssen, L Naesens, et al.
Journal of Medicinal Chemistry
|
March 17, 1995
3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties
S M Siddiqi, X Chen, J Rao, et al.
The Journal of Infectious Diseases
|
February 10, 1999
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group
J P Kleim, M Winters, A Dunkler, et al.
AIDS (London, England)
|
July 24, 1998
Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent
J Balzarini, L Naesens, E Verbeken, et al.
Journal of Medicinal Chemistry
|
July 31, 1998
Discovery of type II (covalent) inactivation of S-adenosyl-L-homocysteine hydrolase involving its "hydrolytic activity": synthesis and evaluation of dihalohomovinyl nucleoside analogues derived from adenosine
S F Wnuk, Y Mao, C S Yuan, et al.
FEBS Letters
|
November 20, 1998
7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase
J Balzarini, A E Gamboa, R Esnouf, et al.
FEBS Letters
|
October 24, 2000
Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase
J Balzarini, B Degrève, A Esteban-Gamboa, et al.
Antiviral Research
|
January 1, 1994
Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates
R Caliò, N Villani, E Balestra, et al.
Antiviral Research
|
June 1, 1993
Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection
R A Heijtink, G A De Wilde, J Kruining, et al.
Molecular Pharmacology
|
December 1, 1992
Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents
N Yamamoto, D Schols, E De Clercq, et al.
Page
of 57